INFU — Infusystem Holdings Share Price
0.000.00%
Last trade - 00:00- $104.45m
- $127.79m
- $134.86m
- 95
- 49
- 27
- 58
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 21.87 | ||
| PEG Ratio (f) | 0.51 | ||
| EPS Growth (f) | 74.85% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.82 | ||
| Price to Tang. Book | 2.21 | ||
| Price to Free Cashflow | 39.78 | ||
| Price to Sales | 0.77 | ||
| EV to EBITDA | 6.59 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 8.02% | ||
| Return on Equity | 4.27% | ||
| Operating Margin | 5.11% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 97.39 | 102.38 | 109.91 | 125.78 | 134.86 | 146.63 | 158.63 | 10.7% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +1121.99 | -91.93 | -98.7 | +4695.24 | +168.2 | +63.84 | +89.27 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
InfuSystem Holdings, Inc. is a national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. Its segments include Patient Services and Device Solutions. Its core service within its Patient Services segment is its Oncology Business. Patient Services supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its Device Solutions segment’s core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment, sell treatment-related consumables, and provide biomedical recertification, maintenance and repair services for oncology practices and other healthcare site settings, including, home care and home infusion providers and others.
Directors
- Scott Shuda NEC (55)
- Carrie Lachance PRE (44)
- Richard Diiorio CEO (46)
- Gregg Lehman VCH (74)
- Barry Steele CFO (50)
- Jeannine Sheehan EVP (47)
- Thomas Ruiz EVP (63)
- Paul Gendron IND (59)
- Darrell Montgomery IND (60)
- Christopher Sansone IND (46)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- August 15th, 2005
- Public Since
- June 15th, 2006
- No. of Shareholders
- 228
- No. of Employees
- 502
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- NYSE MKT
- Shares in Issue
- 21,016,415
- Address
- 3851 West Hamlin Road, ROCHESTER HILLS, 48309
- Web
- https://ir.infusystem.com/
- Phone
- +1 2482911210
- Auditors
- Deloitte & Touche LLP
Upcoming Events for INFU
InfuSystem Holdings Inc Annual Shareholders Meeting
InfuSystem Holdings Inc Annual Shareholders Meeting
Q2 2025 InfuSystem Holdings Inc Earnings Release
Similar to INFU
Acme United
NYSE MKT
Alpha Pro Tech
NYSE MKT
Catheter Precision
NYSE MKT
Electromed
NYSE MKT
Know Labs
NYSE MKT
FAQ
What is the Infusystem Holdings share price?
As of Today at 21:18 UTC, shares in Infusystem Holdings are trading at $4.97. This share price information is delayed by 15 minutes.
How has the Infusystem Holdings share price performed this year?
Shares in Infusystem Holdings last closed at $4.97 and the price had moved by -34.69% over the past 365 days. In terms of relative price strength the Infusystem Holdings share price has underperformed the S&P500 Index by -39.72% over the past year.
What are the analyst and broker recommendations for Infusystem Holdings?
The overall consensus recommendation for Infusystem Holdings is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Infusystem Holdings dividend yield?
Infusystem Holdings does not currently pay a dividend.
Does Infusystem Holdings pay a dividend?
Infusystem Holdings does not currently pay a dividend.
When does Infusystem Holdings next pay dividends?
Infusystem Holdings does not currently pay a dividend.
How do I buy Infusystem Holdings shares?
To buy shares in Infusystem Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Infusystem Holdings?
As of the previous close price of $4.97, shares in Infusystem Holdings had a market capitalisation of $104.45m.
Where are Infusystem Holdings shares listed?
Here are the trading details for Infusystem Holdings:
- Country of listing: United States
- Exchange: ASQ
- Ticker Symbol: INFU
What kind of share is Infusystem Holdings?
Based on an overall assessment of its quality, value and momentum Infusystem Holdings is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Infusystem Holdings share price forecast for 2025?
The analyst consensus target price for shares in Infusystem Holdings is $14.13. That is 184.31% above the last closing price of $4.97.
Analysts covering Infusystem Holdings currently have a consensus Earnings Per Share (EPS) forecast of $0.18 for the next financial year.
Find out moreWhat is the trend in the Infusystem Holdings share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Infusystem Holdings. Over the past six months, its share price has underperformed the S&P500 Index by -19.78%.
As of the last closing price of $4.97, shares in Infusystem Holdings were trading -29.43% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Infusystem Holdings PE Ratio?
The Infusystem Holdings PE ratio based on its reported earnings over the past 12 months is 21.87. The shares last closed at $4.97.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Infusystem Holdings?
Infusystem Holdings' management team is headed by:
- Scott Shuda - NEC
- Carrie Lachance - PRE
- Richard Diiorio - CEO
- Gregg Lehman - VCH
- Barry Steele - CFO
- Jeannine Sheehan - EVP
- Thomas Ruiz - EVP
- Paul Gendron - IND
- Darrell Montgomery - IND
- Christopher Sansone - IND